Aspire-Lakewood Swaps Auditors Amid Going-Concern Warning
ASBP has more than doubled off its 52-week low of $3.309 on light trading volume (0.2× avg).
Summary
Aspire-Lakewood replaced its independent auditor, dismissing Turner Stone and appointing CBIZ CPAs, effective September 24, 2026. The prior auditor's report included a going-concern explanatory paragraph, and the company has disclosed material weaknesses in internal controls.
Key Events · Corporate Governance and Compliance · ASBP
-
Auditor Dismissed
The Audit Committee dismissed Turner Stone & Company, LLP as independent auditor effective September 24, 2026.
-
New Auditor Appointed
CBIZ CPAs P.C. was engaged as the new independent auditor for the fiscal year ending December 31, 2026, effective immediately.
-
Going-Concern Flag
Turner's FY2025 audit report included an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
-
Material Weaknesses Disclosed
The company disclosed material weaknesses in internal control over financial reporting as of December 31, 2025, with disclosure controls and procedures deemed ineffective.
Analysis · ASBP · Life Sciences
On September 24, 2026, the Audit Committee dismissed Turner Stone & Company, LLP and immediately engaged CBIZ CPAs P.C. for the fiscal year ending December 31, 2026. The prior auditor's FY2025 report carried a going-concern explanatory paragraph, and the company has previously disclosed material weaknesses in internal control over financial reporting. An auditor change combined with a going-concern flag and control weaknesses is a governance red flag that warrants close attention.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 37.1% of the 989 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.64%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ASBP was trading at $8.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.5M. The 52-week trading range was $3.31 to $562.92. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.